Tana Smith, MD
Family Medicine · Littleton, CONPI 1932161114
Payments from drug & device makers
Across 81 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$489
- Novo Nordisk$225
- Otsuka America Pharmaceutical, Inc.$123
- Lilly USA, LLC$97
- GSK$88
- Astellas Pharma US Inc$69
- plus $590 from 20 others
What the payments were for
- Food & beverage$1,681100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $489 |
| Novo Nordisk | 11 | $225 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| Lilly USA, LLC | 6 | $97 |
| GSK | 4 | $88 |
| Astellas Pharma US Inc | 3 | $69 |
| Bayer | 3 | $64 |
| Viiv Healthcare Company | 2 | $53 |
| Amgen | 2 | $50 |
| Pfizer | 3 | $49 |
| AstraZeneca | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Medtronic(2 entities) | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Dexcom, Inc. | 1 | $27 |
| Seqirus USA Inc | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $26 |
| IBSA Pharma Inc. | 1 | $22 |
| Abbott | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Cranial Technologies, Inc | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
How this compares
$1,681 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva RespimatTiotropium Bromide | 13 | $7,107 |
| Rosuvastatin Calcium | 62 | $986 |
| Omeprazole | 37 | $734 |
| Atorvastatin Calcium | 90 | $691 |
| Memantine Hcl | 18 | $551 |
| Gabapentin | 18 | $499 |
| Levothyroxine Sodium | 53 | $481 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $348 |
| Amlodipine Besylate | 47 | $259 |
| Lisinopril | 45 | $254 |
| Allopurinol | 11 | $232 |
| Potassium Chloride | 24 | $216 |
| Metoprolol Succinate | 29 | $214 |
| Cefdinir | 11 | $213 |
| Escitalopram Oxalate | 17 | $178 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Littleton
- Frank RauziLittleton$168K
- Julie JeffersLittleton$35K
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.